ALVOPANTAX Trademark

Trademark Overview

On Monday, October 25, 2004, a trademark application was filed for ALVOPANTAX with the United States Patent and Trademark Office. The USPTO has given the ALVOPANTAX trademark a serial number of 79008180. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, October 25, 2014. This trademark is owned by SCHERING AKTIENGESELLSCHAFT. The ALVOPANTAX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in diagnostics and for the treatment of diseases in the fields of oncology, central nervous system diseases, Parkinsons, and multiple sclerosis; pharmaceutical preparations containing hormones for the treatment of diseases in the fields of oncology, central nervous system diseases, Parkinsons, and multiple sclerosis
alvopantax

General Information

Serial Number79008180
Word MarkALVOPANTAX
Filing DateMonday, October 25, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, October 25, 2014
Registration Number3168846
Registration DateTuesday, November 7, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2006

Trademark Statements

Goods and Servicespharmaceutical preparations for use in diagnostics and for the treatment of diseases in the fields of oncology, central nervous system diseases, Parkinsons, and multiple sclerosis; pharmaceutical preparations containing hormones for the treatment of diseases in the fields of oncology, central nervous system diseases, Parkinsons, and multiple sclerosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 13, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Intellectual Property GmbH
Party Type32 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressDE
Party NameBayer Pharma Aktiengesellschaft
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressDE
Party NameSCHERING AKTIENGESELLSCHAFT
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDE
Party NameSCHERING AKTIENGESELLSCHAFT
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE
Party NameSCHERING AKTIENGESELLSCHAFT
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events

Event DateEvent Description
Friday, May 22, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, May 22, 2015DEATH OF INTERNATIONAL REGISTRATION
Friday, November 14, 2014TOTAL INVALIDATION PROCESSED BY THE IB
Friday, August 29, 2014GENERIC MADRID TRANSACTION SENT TO IB
Friday, August 29, 2014GENERIC MADRID TRANSACTION CREATED
Tuesday, May 13, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 13, 2013CANCELLED SECTION 71
Friday, September 21, 2012CHANGE OF OWNER RECEIVED FROM IB
Friday, March 2, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, May 1, 2008CHANGE OF OWNER RECEIVED FROM IB
Friday, March 7, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 14, 2007FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 14, 2007FINAL DISPOSITION PROCESSED
Wednesday, June 6, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 7, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, August 22, 2006PUBLISHED FOR OPPOSITION
Thursday, August 10, 2006NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, August 2, 2006NOTICE OF PUBLICATION
Thursday, July 27, 2006NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, July 27, 2006NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, June 28, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 23, 2006ASSIGNED TO LIE
Thursday, June 22, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 16, 2006AMENDMENT FROM APPLICANT ENTERED
Tuesday, February 14, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 25, 2006PETITION GRANTED - RESPONSE RECEIVED
Tuesday, February 14, 2006PETITION TO REVIVE-RECEIVED
Tuesday, February 14, 2006PAPER RECEIVED
Friday, February 17, 2006ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, February 16, 2006ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, October 20, 2005IRREGULARITY FROM IB EXAMINED BY MPU
Thursday, August 4, 2005REFUSAL PROCESSED BY IB
Friday, July 22, 2005IRREGULARITY ON REFUSAL FROM IB
Monday, July 18, 2005NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, May 28, 2005NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 27, 2005NON-FINAL ACTION WRITTEN
Friday, May 27, 2005ASSIGNED TO EXAMINER
Monday, February 28, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, February 24, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

alvopantax diseases system nervous parkinsons sclerosis multiple pharmaceutical central preparations oncology